These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22360826)

  • 1. Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device.
    Selgrade BP; Truskey GA
    Artif Organs; 2012 Apr; 36(4):E89-96. PubMed ID: 22360826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
    Bartoli CR; Kang J; Motomura T
    J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
    Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
    Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
    Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
    Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
    Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis and von Willebrand factor degradation in mechanical shuttle shear flow tester.
    Shiraishi Y; Tachizaki Y; Inoue Y; Hayakawa M; Yamada A; Kayashima M; Matsumoto M; Horiuchi H; Yambe T
    J Artif Organs; 2021 Jun; 24(2):111-119. PubMed ID: 33559766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress and Exposure Time on von Willebrand Factor Degradation.
    Jhun CS; Siedlecki C; Xu L; Lukic B; Newswanger R; Yeager E; Reibson J; Cysyk J; Weiss W; Rosenberg G
    Artif Organs; 2019 Feb; 43(2):199-206. PubMed ID: 30374981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a mathematical model for evaluating shear-induced damage of von Willebrand factor.
    Li Y; Xi Y; Wang H; Sun A; Wang L; Deng X; Chen Z; Fan Y
    Comput Biol Med; 2023 Sep; 164():107379. PubMed ID: 37597407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual Variability in von Willebrand Factor Fragility in Response to Shear Stress: A Possible Clue for Predicting Bleeding Risk.
    Sakatsume K; Akiyama M; Sakota D; Hijikata W; Horiuchi H; Maruyama O; Saiki Y
    ASAIO J; 2022 Sep; 68(9):1128-1134. PubMed ID: 34967782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-frequency operation of pulsatile ventricular assist devices: A computational study on circular and elliptically shaped pumps.
    Loosli C; Rupp S; Thamsen B; Rebholz M; Kress G; Meboldt M; Ermanni P
    Int J Artif Organs; 2019 Dec; 42(12):725-734. PubMed ID: 31277562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index.
    Fraser KH; Zhang T; Taskin ME; Griffith BP; Wu ZJ
    J Biomech Eng; 2012 Aug; 134(8):081002. PubMed ID: 22938355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleeding.
    Hennessy-Strahs S; Kang J; Krause E; Dowling RD; Rame JE; Bartoli CR
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):196-204. PubMed ID: 35501195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.
    Netuka I; Kvasnička T; Kvasnička J; Hrachovinová I; Ivák P; Mareček F; Bílková J; Malíková I; Jančová M; Malý J; Sood P; Sundareswaran KS; Connors JM; Mehra MR
    J Heart Lung Transplant; 2016 Jul; 35(7):860-7. PubMed ID: 27435529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices.
    Zhou Y; Qin S; Hilton T; Tang L; Cruz M; Hernandez R; Moake JL; Tian Q; Frazier OH; Dong JF; Nascimbene A
    ASAIO J; 2017; 63(6):849-853. PubMed ID: 28682993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical simulation analysis of multi-scale computational fluid dynamics on hemodynamic parameters modulated by pulsatile working modes for the centrifugal and axial left ventricular assist devices.
    Huo M; Giridharan GA; Sethu P; Qu P; Qin K; Wang Y
    Comput Biol Med; 2024 Feb; 169():107788. PubMed ID: 38091724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.